The Health-Related Quality of Life, Work Productivity, Healthcare Resource Utilization, and Economic Burden Associated with Levels of Suicidal Ideation Among Patients Self-Reportin...

by Benson C, Singer D, Carpinella CM, Shawi M, Alphs L
Published 2021-01-01

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

by Sliwa JK, Bossie CA, Fu D-J, Turkoz I, Alphs L
Published 2012-08-01

Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies

by Gopal S, Liu Y, Alphs L, Savitz A, Nuamah I, Hough D
Published 2013-09-01

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose

by Samtani MN, Nuamah I, Gopal S, Remmerie B, Sliwa JK, Alphs L
Published 2013-05-01

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics

by Alphs L, Bossie CA, Sliwa JK, Fu DJ, Ma YW, Hulihan J
Published 2013-03-01

Erratum

by Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L
Published 2012-09-01

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

by Samtani MN, Sheehan JJ, Fu D-J, Remmerie B, Sliwa JK, Alphs L
Published 2012-07-01